Gerard Brophy - Feb 23, 2022 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Stock symbol
AVTR
Transactions as of
Feb 23, 2022
Transactions value $
-$175,665
Form type
4
Date filed
2/25/2022, 08:32 PM
Previous filing
Feb 22, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Sale -$103K -3.06K -2.39% $33.79 125K Feb 23, 2022 Direct F1, F2
transaction AVTR Common Stock Award $0 +15.1K +12.07% $0.00 140K Feb 23, 2022 Direct F3
transaction AVTR Common Stock Tax liability -$72.3K -2.04K -1.46% $35.39 138K Feb 25, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTR Stock Options (Right to Buy) Award $0 +43.7K $0.00 43.7K Feb 23, 2022 Common Stock 43.7K $33.09 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.75 to $33.94 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above.
F3 Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 23, 2023.
F4 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSU's.
F5 Reflects a grant of stock options that vest in four equal annual installments beginning on February 23, 2023.